Middle East Medical Cannabis Market, by Product Type, 2018-2027

Growth Outlook

• The 2027 portion of the Middle East Medical Cannabis Market, by Product Type, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 37 Mn in 2026 and is projected to reach USD 45 Mn by 2027 — a gain of about 22% over the forecast period, translating to a CAGR in the double digits.
• The Middle East medical cannabis market has been gaining significant attention in recent years due to the increasing acceptance of cannabis for its therapeutic properties. This region, which was once strictly against the use of cannabis, is now gradually opening up to the idea of medical cannabis for the treatment of various health conditions.
• What the regional split looks like (2026): Dissolvables/Powders leads, holding roughly 43% of segment value — the single largest regional share. Oil is the second-largest contributor. Solids and Ointments & Creams make up the remainder, in descending order.
• By 2027, Dissolvables/Powders alone is expected to reach USD 19 Mn, with Oil at USD 16 Mn.

Market Dynamics

The Middle East medical cannabis market has been gaining significant attention in recent years due to the increasing acceptance of cannabis for its therapeutic properties. This region, which was once strictly against the use of cannabis, is now gradually opening up to the idea of medical cannabis for the treatment of various health conditions. One of the factors driving the demand for medical cannabis in the Middle East is the rising prevalence of chronic diseases such as cancer, multiple sclerosis, and epilepsy. These diseases not only impact the physical well-being of individuals but also have a significant impact on their mental health. As a result, there has been a growing interest in exploring alternative treatment options, including medical cannabis. In terms of product type, the Middle East medical cannabis market can be segmented into oils, tinctures, capsules, and creams. Oils and tinctures are the most commonly used medical cannabis products in the region. They are preferred due to their easy usage, versatility, and faster onset of action. These products can be consumed sublingually or mixed with food and beverages, making them convenient for patients with different preferences.

Another product type gaining traction in the Middle East medical cannabis market is capsules. These are preferred by patients who want a precise and consistent dosage of cannabis. Capsules come in various strengths and can be taken orally, making them easy to use for patients who may have difficulty consuming other forms of medical cannabis. Creams and topicals are also gaining popularity in the Middle East for their localized pain relief and anti-inflammatory properties. These products are applied directly to the affected area and offer a more targeted approach to treating conditions such as arthritis and skin disorders. Moreover, there has been a rising demand for hemp-derived CBD products in the Middle East due to their non-psychoactive and anti-inflammatory properties. CBD oils and tinctures are increasingly being used for managing symptoms associated with conditions such as anxiety, depression, and chronic pain. In conclusion, the demand for medical cannabis products in the Middle East is being driven by the growing acceptance of cannabis for medicinal purposes. With an increasing focus on research and development, it is expected that new and innovative medical cannabis products will enter the market, further contributing to the growth of the industry.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2024.